论文信息 - Oophorectomy and risk of contralateral breast cancer among BRCA1 and BRCA2 mutation carriers - 字舞流文

Oophorectomy and risk of contralateral breast cancer among BRCA1 and BRCA2 mutation carriers

F. Couch | O. Olopade | B. Karlan | P. Møller | W. Foulkes | J. Lubiński | S. Neuhausen | N. Tung | A. Eisen | C. Singer | S. Narod | J. Kotsopoulos | H. Lynch | P. Ainsworth | P. Sun | S. Armel | L. Senter | J. Weitzel | J. Gronwald | R. Fruscio

[1] O. Olopade,et al. Predictors of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers , 2011, British Journal of Cancer.

[2] W. Chung,et al. Risks of Breast, Ovarian, and Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers , 2017, JAMA.

[3] Diana Eccles,et al. Cancer risks for BRCA1 and BRCA2 mutation carriers: results from prospective analysis of EMBRACE. , 2013, Journal of the National Cancer Institute.

[4] Risk of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers: a 30-year semi-prospective analysis , 2015, Familial Cancer.

[5] B. Karlan,et al. Impact of oophorectomy on cancer incidence and mortality in women with a BRCA1 or BRCA2 mutation. , 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[6] O. Olopade,et al. A Comparison of Bilateral Breast Cancers in BRCA Carriers , 2005, Cancer Epidemiology Biomarkers & Prevention.

[7] H. Meijers-Heijboer,et al. Breast cancer risk after salpingo-oophorectomy in healthy BRCA1/2 mutation carriers: revisiting the evidence for risk reduction. , 2015, Journal of the National Cancer Institute.

[8] Rosalind Eeles,et al. Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality. , 2010, JAMA.

[9] Päivi Heikkilä,et al. Pathology of Breast and Ovarian Cancers among BRCA1 and BRCA2 Mutation Carriers: Results from the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA) , 2011, Cancer Epidemiology, Biomarkers & Prevention.

[10] W. Foulkes,et al. A prior diagnosis of breast cancer is a risk factor for breast cancer in BRCA1 and BRCA2 carriers. , 2014, Current oncology.

[11] Y. Hatano,et al. Molecular Trajectory of BRCA1 and BRCA2 Mutations , 2020, Frontiers in Oncology.

[12] B. Karlan,et al. Bilateral Oophorectomy and Breast Cancer Risk in BRCA1 and BRCA2 Mutation Carriers , 2017, Journal of the National Cancer Institute.

[13] Jinbo Chen,et al. RE: Breast Cancer Risk After Salpingo-Oophorectomy in Healthy BRCA1/2 Mutation Carriers: Revisiting the Evidence for Risk Reduction. , 2015, Journal of the National Cancer Institute.